The multi-vessel and diffuse coronary spasm is a risk factor for persistent angina in patients received anti-angina medication

Keyphrases

• Risk Factors 100%
• Angina 100%
• Multivessel 100%
• Coronary Spasm 100%
• Persistent Angina 100%
• Diffuse Spasm 90%
• Spasm 30%
• Clinical Follow-up 30%
• Refractory Angina 20%
• Coronary Angiography 20%
• Confidence Interval 20%
• Adverse Cardiac Events 20%
• 3-group 20%
• Hazard Ratio 20%
• Acetylcholine Provocation Test 10%
• Clinical Outcomes 10%
• Myocardial Infarction 10%
• High Incidence 10%
• Total Mortality 10%
• Coronary Artery Spasm 10%
• Multivariable 10%
• Percutaneous Coronary Intervention 10%
• Confounding Factors 10%
• Adverse Clinical Outcomes 10%
• Cox Proportional Hazards Regression Analysis 10%
• Major Adverse Cardiovascular Events 10%
• Cerebrovascular Accident 10%
• 3-year Follow-up 10%
• Single Center 10%
• Chronic Chest Pain 10%
• Cardiovascular Events 10%
• Optimal Medical Therapy 10%
• All-comers Registry 10%

Medicine and Dentistry

• Angina pectoris 100%
• Coronary Vasospasm 100%
• Drug Therapy 100%
• Muscle Spasm 100%
• Coronary Angiography 16%
• Major Adverse Cardiac Event 16%
• Hazard Ratio 16%
• Recurrent Disease 8%
• Acetylcholine 8%
• Provocation Test 8%
• Thorax Pain 8%
• Myocardial Infarction 8%
• Cardiovascular System 8%
• Cardiovascular Disease 8%
• Percutaneous Coronary Intervention 8%
• Combination Therapy 8%
• Apoplexy 8%
• Proportional Hazards Model 8%
• Pyriprole 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronary Artery Spasm 100%
• Muscle Spasm 100%
• Major Adverse Cardiac Event 16%
• Thorax Pain 8%
• Heart Infarction 8%
• Combination Therapy 8%
• Acetylcholine 8%
• Provocation Test 8%
• Recurrent Disease 8%
• Cerebrovascular Accident 8%
• Pyriprole 8%
• Cardiovascular Disease 8%